Tech billionaires fund longevity ventures to 'defeat' biology

Bezos, Altman, Zuckerberg, and Thiel are investing heavily in biotechnology startups aimed at extending human lifespan, signaling a shift from luxury spending to life-extension research. The scope and success of these ventures remain uncertain, but the influx of capital could accelerate breakthroughs in aging science.